AKT1 and sarcoma: Gains affected a slightly higher number of different genes belonging to cell cycle regulation (AKT1, CCND3, CDK4, DDR2, EPCAM, FLCN, RHOA, CCNE1, and MYC) and DNA damage repair (MSH2), highlighting how these pathways play a fundamental role in the biology of sarcomas.